MACROGENICS INC (MGNX:NASDAQ)
$4.4 -0.1 (-2.2222%)
Analysed MACROGENICS INC (MGNX:NASDAQ) News Sources
VERAXA Biotech Secures $27.5M Financing, to Go Public Via SPAC
28-05-2026
yahoo.com
Akari Therapeutics Highlights 1st ASCO Abstract Acceptance
28-05-2026
yahoo.com
How The MacroGenics (MGNX) Story Is Shifting With ADC Pipeline Bets And 2026 Data Risks
07-06-2026
yahoo.com
Sanofi Wins FDA Nod for Expanded Use of T1D Drug in Children
15-06-2026
yahoo.com
MacroGenics to Receive Milestone Payment from Sanofi for Recent TZIELD® Approval
22-06-2026
yahoo.com
MacroGenics Completes Sale of GMP Manufacturing Operations to Bora Pharmaceuticals
02-07-2026
yahoo.com
Bora Pharmaceuticals Completes Acquisition of MacroGenics' Rockville Manufacturing Operations
02-07-2026
yahoo.com
MacroGenics (MGNX) is a Great Momentum Stock: Should You Buy?
02-07-2026
yahoo.com
VERAXA Biotech Stock in Focus as Lead Cancer Program Reaches Development Milestone
02-07-2026
yahoo.com
R&D Change Underlines Sanofi SA (SNY) Prospects as One of the Best Dividend Stocks to Buy
05-07-2026
yahoo.com
What is the current price of MACROGENICS INC (MGNX:NASDAQ)?
The current price of MACROGENICS INC (MGNX:NASDAQ) is $4.4.
MACROGENICS INC (MGNX:NASDAQ) absolute price change since previous trading day?
The absolute price change of MACROGENICS INC (MGNX:NASDAQ) since the previous trading day is $-0.1.
MACROGENICS INC (MGNX:NASDAQ) percentage price change since previous trading day?
The percentage price change of MACROGENICS INC (MGNX:NASDAQ) since the previous trading day is -2.2222%.
What is the most recent average sentiment score for MACROGENICS INC (MGNX:NASDAQ)?
The most recent average sentiment score for MACROGENICS INC (MGNX:NASDAQ) is 66 out of 100.
What is the most recent average sentiment for MACROGENICS INC (MGNX:NASDAQ)?
The most recent sentiment for MACROGENICS INC (MGNX:NASDAQ) is .
SEC-8K** Filing Available For MACROGENICS INC (MGNX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.